Objective(s): The aim of this study was to determine if ultralightweight polypropylene mesh reduced the risk of mesh/suture exposure after sacrocolpopexy compared with heavier-weighted polypropylene. Conclusions: Both mesh choice and suture selection remained independent predictors of mesh/suture exposure, with heavier meshes increasing and monofilament suture decreasing rates of mesh/suture exposure. Based on this study, surgeons may consider use of delayed-absorbable, monofilament suture over nonabsorbable braided suture for attachment of vaginal mesh to reduce the risk of mesh/suture exposure when using mesh.
P elvic organ prolapse (POP) is a common condition affecting approximately 50% of women older than 50 years. 1, 2 The prevalence of POP ranges from 2% to 30%. Samuelsson et al 1 detected a 2% rate of prolapse at the introitus based on physical examination and 30% for any degree of prolapse. This is confirmed by Nygaard et al, 2 who detected a 3% rate of symptomatic POP in US women based on an experience of bulging or something falling out of the vaginal area. The number of US women with POP is projected to increase 46% from 3.3 million to 4.9 million from 2010 to 2050 as a result of changing demographics. 3 The lifetime risk of any surgical treatment for POP is estimated between 11% and 19%. [4] [5] [6] Sacrocolpopexy is a common surgical treatment for POP and is arguably the criterion standard in regard to effectiveness because of lower rates of recurrent prolapse. [6] [7] [8] [9] [10] While sacrocolpopexy is an effective treatment of POP, it is not without complications; specifically mesh exposure with the introduction of synthetic mesh materials. The historical prevalence of mesh exposure in sacrocolpopexy is 2% to 10%. [11] [12] [13] [14] [15] [16] Numerous potentially modifiable risk factors have been studied with the aims of reducing mesh/suture exposure rates. Factors that have been associated with mesh/suture exposure include smoking, estrogen status, mesh type, suture type, stage of prolapse, concomitant hysterectomy, and additional procedures at time of sacrocolpopexy. The odds ratio (OR) for mesh exposure in smokers ranges from 4.4 to 5.2. 13, 14 Estrogen status has been a controversial risk factor with studies that have reported conflicting results. 12, 14, 17, 18 Another controversial risk factor is concomitant hysterectomy. Numerous studies have demonstrated that abdominal, vaginal, and laparoscopic-assisted vaginal hysterectomies at time of sacrocolpopexy increase the risk of mesh exposure. 15, 19 Tan-Kim et al 15 reported a 5% rate of mesh exposure in patients with prior hysterectomy or supracervical hysterectomy at time of sacrocolpopexy compared with 23% erosion rate for patients with concomitant total vaginal hysterectomy or laparoscopic-assisted vaginal hysterectomy at time of sacrocolpopexy. Akyol et al 19 showed an increased risk of mesh exposure in patients with concomitant hysterectomy versus prior hysterectomy (47.4% vs 23.8%). Conversely, conflicting data by Wu et al, 12 Brizzolara and Pillai-Allen, 20 and Marinkovic 21 suggest that concomitant hysterectomy does not increase mesh exposure. Other identified risk factors include more advanced stages of prolapse (stages III and IV) and performance of more than 3 additional procedures at time of sacrocolpopexy. 19 In addition, both mesh and suture types have been implicated in higher mesh exposure rates including silicone and expanded polytetrafluoroethylene (Gore-Tex; W. L. Gore & Associates, Flagstaff, Ariz) mesh, as well as polyester suture (Ethibond; Ethicon US, Somerville, NJ), respectively. 11, 14, 22 Type 1 (Amid classification) knitted, polypropylene mesh has become the preferred choice for sacrocolpopexy because of its biologically inert, structural and biochemical properties. More recently, ultralightweight and partially absorbable lightweight materials have been introduced to market, with the goal of reducing adverse events associated with synthetic graft implantation. Knowledge of the risk of mesh/suture exposure when these newer synthetic materials are implanted in vivo would provide surgical guidance toward improving outcomes in women with POP while minimizing adverse events.
The aim of our study was to determine if mesh type for sacrocolpopexy was an independent predictor of mesh/suture exposure after controlling for established predictors during bivariate analysis using a case-control design. Specifically, we were interested in determining if ultralightweight polypropylene mesh was associated with an increased or decreased risk of mesh/suture exposure compared with other heavier-weighted polypropylene after sacrocolpopexy.
MATERIALS AND METHODS
The institutional review board approved this retrospective case-control of sacrocolpopexy mesh/suture exposure at an academic teaching institution from 2003 to 2013. A query of sacrocolpopexy based on current procedural terminology (CPT) codes was performed including all abdominal, laparoscopic, and robot-assisted procedures. Sacrocolpopexy cases were cross-referenced with mesh/suture exposure CPT codes during the same period to create the case list. CPT codes for mesh/suture exposure included all gynecologic mesh/suture exposures. Operative reports for both cases and control subjects were reviewed to verify type of mesh procedure and allow exclusion of exposures from procedures other than sacrocolpopexy. Cases were defined by the presence of mesh/suture exposure and categorized as exposure of mesh, suture, or mesh plus suture. During chart review, any control subjects with exposure of suture or mesh based on documented office examination were added to the case list. A 2:1 control-to-case list was created by computer-generated randomization of patients who had a sacrocolpopexy without subsequent mesh/suture exposure during the same period.
Data , were considered our heavyweight polypropylene of choice.
All procedures were performed by 3 surgeons in conjunction with residents and urogynecology fellows during the study period. Patients were routinely followed up at 6 weeks, 6 months, and yearly thereafter independent of mesh/suture exposure status. Surgery type was categorized as follows: mesh augmented apical suspension procedures were categorized as conventional laparoscopic sacrocolpoperineopexy when an abdominovaginal posterior colporrhaphy without levator plication was performed prior to anterior, posterior, apical vaginal, and sacral attachment of mesh. The first stage included a vaginal dissection where a traditional posterior colporrhaphy without levator plication was augmented by the overlaid distal laparoscopic sacrocolpoperineopexy posterior mesh leaflet attached to the iliococcygeal fascia laterally and the perineal body distally. The second stage included attaching the mesh to the posterior vaginal wall laparoscopically in the standard technique. Procedures were categorized as conventional laparoscopic sacrocolpopexy when traditional posterior colporrhaphy without levator plication or no posterior colporrhaphy was performed based on the surgeon's examination of the patient's anatomy after apical suspension with anterior, posterior, apical vaginal, and sacral attachment of mesh. Surgical technique moved toward minimally invasive approaches over the course of the study with a transition to laparoscopic sacrocolpopexies in 2006. In addition, graph and suture selection evolved over the course of the study based on the desire to reduce mesh burden for individual patients as lightweight materials became available. If concomitant hysterectomy was performed, the vaginal cuff was closed with either Vicryl or polydioxanone suture (PDS) suture in a full-thickness, single-layer closure. There were only 5 total laparoscopic hysterectomies where energy was used for the colpotomy.
Exclusion criteria included patients with any mesh/suture exposure from other procedures including tension-free vaginal tape, transoburator tape, anterior and posterior colporrhaphy with transvaginal mesh, or any other sling, lift, or suspension procedures using mesh other than sacrocolpopexy. Cases with more than 1 type of mesh procedure were examined case by case to review mesh type, suture type, and location of mesh/suture exposure to determine inclusion versus exclusion. Sacrocolpopexy revision procedures and subsequent mesh/suture exposures were included.
Our null hypothesis was that ultralightweight polypropylene mesh was not associated with either an increase or decrease in mesh/suture exposure rates compared with heavier-weighted polypropylene. Our alternate hypothesis was that ultralightweight polypropylene mesh was associated with either an increase or decrease in mesh/suture exposure rates compared with heavierweighted polypropylene.
During bivariate analysis, we compared the means of normally distributed continuous data using separate variance or pooled variance Student t tests where appropriate. We compared non-normally distributed data using the Mann-Whitney U tests. Categorical data were compared using Pearson χ 2 tests. During multivariate analysis, logistic regression was used to assess independent risk factors. We entered all potential independent predictors of mesh/suture exposure with P < 0.1 identified during bivariate analysis. In block 1 of the logistic regression equation, we entered all potential independent predictors of mesh/suture exposure identified during bivariate analysis except for mesh type. In block 2 of the logistic regression equation, we entered mesh/suture type to determine if it independently predicted mesh/suture exposure after controlling for all known predictors identified during bivariate analysis. Odds ratios with 95% confidence interval (CI) estimates for mesh/suture exposure risk were calculated for all 2 Â 2 comparisons during bivariate and multivariate analysis. Significance was determined by P < 0.05 and 95% CIs that excluded 1.0 for risk estimates. Missing data were not imputed, which explains why study population counts differ depending on the analysis. Statistical analysis was performed with Statistical Package for Social Sciences software (released 2013, IBM SPSS Statistics for Windows, version 22.0, IBM Corp, Armonk, NY).
RESULTS
There were 133 cases of mesh/suture exposure identified that were matched to 261 control subjects of the 1247 sacrocolpopexies performed between 2003 and 2013. Figure 1 is the breakdown of mesh/suture exposure by year. Mesh exposures alone were identified in 45.2% of cases compared with suture exposures and combined mesh and suture exposures identified in 18.5% and 36.3% of cases, respectively. The cases and control subjects were similar with respect to age at time of surgery, BMI, estrogen status, preoperative comorbidities as measured by the Charlson Comorbidity Index, number of additional surgeries at time of sacrocolpopexy, and concomitant hysterectomy ( Table 1) . Type of concomitant hysterectomy was not associated with mesh/suture exposure although we did notice a higher number of supracervical hysterectomies in our control group (5) compared with our cases (1), suggestive of a protective effect for mesh/suture exposure if an increasing number of supracervical hysterectomies were performed. Cases differed from control subjects in several areas including smoking, prior sacrocolpopexy preoperative leading edge of prolapse, ICS stage IV prolapse, duration of surgery, immediate and delayed perioperative complications as measured by Clavien-Dindo scores and the CCI, respectively, and mesh and suture types (Table 2) .
Consistent with prior studies, current smokers were at an increased rate of mesh/suture exposure compared with past or nonsmokers (50% vs 23.9% vs 34.4%, P = 0.015). Study subjects with prior sacrocolpopexy were less likely to develop mesh/suture exposure during the study period (OR, 0.14; 95% CI, 0.02-1.1; P = 0.03). The average preoperative leading edge was more advanced in mesh/suture exposure cases compared with control subjects (3.1 ± 2.6 vs 2.6 ± 2.1 cm, P < 0.03). Stage IV prolapse, regardless if predominately anterior (OR, 3.52; 95% CI, 1.61-7.68), posterior (OR, 3.07; 95% CI, 1.38-6.82), or uterine/ cuff (OR, 2.92; 95% CI, 1.26-6.76), was a significant risk factor for mesh/suture exposure. ICS prolapse stages II and III were not risk factors for mesh/suture exposure. The duration of surgery also contributed to an increased risk of mesh/suture exposure, with the average duration of operation in cases lasting 423.5 ± 106.7 minutes compared with 400.1 ± 70.6 minutes in control subjects (P = 0.045). This was irrespective of the number of additional procedures at time of sacrocolpopexy as the number of additional procedures in mesh/suture exposure cases was 4.5 ± 1.2 compared with 4.6 ± 1.4 (P = 0.624). Duration of follow-up was longer in cases of mesh/suture exposure compared with that in control subjects (38.6 ± 33.44 vs 15.82 ± 16.58 months, P < 0.001) despite collection of data from the same study period. Immediate and delayed perioperative complications were both associated with increased risk of mesh/suture exposure. There was a linear association between increasing Clavien-Dindo score and mesh/suture exposure risk. Study subjects with Clavien-Dindo score of 3 or greater had mesh/suture exposure rates of 100% compared with subjects with lower scores (score 0, 28.8%; score 1, 54.2%; score 2, 64.7%). The CCI scores were similarly higher in cases than those in control subjects (2.62 ± 8.11 vs 0.31 ± 2.29, P < 0.001).
Bivariate analysis of mesh and suture type is summarized in 
DISCUSSION
Prior research has identified numerous preoperative and intraoperative risk factors for mesh/suture exposure including smoking, estrogen status, stage of prolapse, concomitant hysterectomy, number of additional procedures at time of sacrocolpopexy, and mesh and suture type. Ultralightweight and partially absorbable lightweight polypropylene mesh has been introduced to market with the goal of reducing adverse events associated with synthetic graft implantation. Knowledge of the risk of mesh/suture exposure when these newer synthetic materials are implanted in vivo would provide surgical guidance toward improving the outcomes in women with POP while minimizing adverse events. In our study, we found that use of medium-weight and other heavier-weighted polypropylene meshes were associated with an increased risk of mesh/suture exposure. Ultralightweight polypropylene mesh was not associated with mesh/suture exposure after controlling for other identified risk factors during bivariate analysis. Use of polyester suture for vaginal mesh attachment also increased the risk of mesh/suture exposure independently.
Smoking and the effects of nicotine on wound healing are well studied in the literature. Lowman et al 13 specifically looked at smoking in relation to mesh exposure in abdominal sacrocolpopexy and found that smokers had higher rates of mesh exposure (25.9% vs 7.4%, P = 0.01). This is consistent with our results that confirmed higher rates of mesh/suture exposure in smokers during bivariate analysis. Preoperative discussions regarding smoking cessation should continue to be an important part of surgical counseling to decrease individual risks for mesh/suture exposure. A literature review revealed a paucity of studies that looked specifically at estrogen status as an independent risk factor for mesh exposure, but estrogen has been analyzed as a risk factor in studies looking at other primary risk factors such as concomitant hysterectomy, mesh type, suture type, and so on. 12, 22 In our study, estrogen status was not a risk factor for mesh/suture exposure. Heterogeneity with regard to documentation of estrogen type, indication for use (vasomotor symptoms vs vaginal atrophy), route of delivery (systemic vs vaginal), preoperative or postoperative use, and duration of use makes evaluation of estrogen status within and between studies difficult. Based on conflicting data, there is a need for welldesigned studies looking at the effects of estrogen on mesh/suture exposure to help clarify this risk factor. A recent randomized trial by Sun et al 23 showed that preoperative use of vaginal estrogen twice weekly for 4 to 6 weeks was noninferior to nonuse for risk of mesh exposure at 1 year after transvaginal mesh placement. Similar to Akyol et al, 19 our study revealed that advanced prolapse stage is a risk factor for mesh/suture exposure. Our study indicated that only ICS stage IV prolapse was a significant predictor of mesh/suture exposure, whereas Akyol et al showed that stage III or greater was predictive as well. It is postulated that advancing stage of prolapse is associated with thinning of the vaginal mucosa, thus providing less robust tissue available for vaginal mesh attachment, leading to higher rates of mesh/suture exposure. Conversely, vaginal wall thickening and scarring associated with previous sacrocolpopexy may explain why this factor was associated with a decreased risk of mesh/suture exposure during bivariate analysis. Physicians can use this information to counsel patients about their risks and possible potential benefit of surgical intervention at an earlier stage.
Furthermore, Akyol et al 19 reported that 3 or more additional procedures at time of sacrocolpopexy conferred greater risk of mesh exposure. Our study did not reveal a difference in mesh/suture exposure rates with the addition of multiple procedures at time of sacrocolpopexy; however, duration of procedure was a significant predictor of mesh/suture exposure during bivariate analysis. Many factors impact duration of procedure including instruction of learners and additional procedures at time of sacrocolpopexy. In addition, it is possible that longer procedure times are a proxy for surgical complexity such as scar or mesh revision, adhesiolysis, and/or greater blood loss, which may be an unmeasured, independent risk factor. While the number of additional surgeries during sacrocolpopexy was not a risk factor for mesh/suture exposure, study subjects with a prior incontinence surgery remained at increased risk of mesh/suture exposure after multivariate regression analysis. A chronic inflammatory response at the surgical site related to suture or mesh used for continence may cause activation of acute-phase reactants at the proximal vagina promoting mesh/ suture exposure after sacrocolpopexy. This hypothesis warrants further investigation.
Lastly, it appears that immediate postoperative complications are an important predictor of mesh/suture exposure. While no surgeon wants intraoperative or postoperative complications, knowing that immediate complication increases the risk of mesh/suture exposure can help providers counsel patients postoperatively and monitor at-risk patients more closely.
Mesh type used in sacrocolpopexy has and continues to evolve as studies report comparative biomechanical properties and mesh/ suture exposure data. Mesh weights, pore size, and softness have been modified in hopes of reducing mesh/suture exposure, contractile pain, dyspareunia, and infection rates. PROLENE Soft was introduced after 2000 and was the medium-weight mesh type used following heavier-weighted polypropylene meshes in the beginning of the study period. Ultrapro was introduced to market in 2004 and was not utilized by our practice in large numbers. Restorelle came to market late 2010, and there has been significant utilization of the newest generation of ultralightweight mesh for sacrocolpopexy, making possible the analysis of long-term complications such as mesh/suture exposure. Our study is one of the first to look at mesh/suture exposure rates for ultralightweight polypropylene mesh. Our study revealed that ultralightweight polypropylene mesh decreased the risk of mesh/suture exposure during bivariate analysis, but ultralightweight polypropylene mesh neither increased nor decreased the risk of mesh/suture exposure after controlling for other identified risk factors. Because mesh/suture exposure can take years to develop, ultralightweight polypropylene mesh may remain unassociated with mesh/suture exposure or may become an independent risk factor with the passage of time. Reexamination of mesh/suture exposure rates using ultralightweight polypropylene mesh/suture for sacrocolpopexy at a later time may yield different conclusions. However, at this time, it appears that ultralightweight polypropylene mesh neither increases nor decreases mesh/suture exposure compared with heavier-weighted polypropylene meshes, which are the strongest risk factors for mesh/suture exposure found in our study.
As previously stated, suture selection appears to be an important factor for reducing mesh/suture exposure complications. Our study looked at suture selection for vaginal cuff closure, vaginal mesh attachment, and sacral attachment. Suture selection from all sites were collected as inflammation, graph rejection, suture rejection, and poor wound healing at any of the suture placement sites have the potential to impact other sites through direct extension. In a study by Shepard et al 22 that examined suture selection and exposure rates, they found that PDS had lower rates of mesh exposure than polyester (6/161 [3.7%] vs 0/254 [0%], P = 0.002) without increasing sacrocolpopexy failure. The results of our study confirm that PDS is associated with decreased rates of exposure, whereas polyester was independently associated with increased risk of exposure during multivariate analysis. This may be due to the braided nature of polyester suture that is a potential nidus for infection, leading to poor healing and subsequent mesh/ suture exposure. A similar trend was seen with the use of expanded polytetrafluoroethylene sutures for vaginal mesh attachment because it behaves similar to a braided nonabsorbable suture, although sample size considerations limit the validity of this conclusion. We are unable to comment on the value of nonabsorbable monofilament suture based on low utilization rates. Our study confirms that use of delayed absorbable monofilament suture is a better choice for vaginal mesh attachment during sacrocolpopexy in regard to mesh/suture exposure.
Our research provides no evidence that use of ultralightweight mesh and PDS suture provides equivalent success rates compared with heavier meshes using permanent multifilament suture. However, the association of these materials with high rates of exposure discourages our continued usage because of these risks.
Limitations of this study are its retrospective and nonrandomized nature. Missing data from any retrospective case-control study could lead to systematic error in results reporting, leading to biased interpretations from true data. Results are from the experience of a single institution and thus may lack generalizability. Surgeon experience could confound the relationship between mesh/suture type and exposure; however, surgical technique has remained constant over 25 years of surgeon experience. Utilization of CPT codes to generate the case list may underestimate the true rate of mesh/suture exposure because CPT codes capture only surgical procedures for mesh and suture excision and fail to capture office removal and patients treated with vaginal estrogen. However, exposures identified during chart review of the control group were added to the case list. There are advantages and disadvantages to using CPT rather than International Classification of Diseases, 10th Revision codes to categorize cases and control subjects. The disadvantage of using CPT codes is that we can draw conclusions only based on mesh/suture exposure requiring surgical intervention rather than total mesh/suture exposures treated by nonsurgical and surgical interventions. The advantage is that use of CPT rather than International Classification of Diseases, 10th Revision provides a definitive nondebatable primary end point of interest to draw responsible conclusions from when identifying risk factors that may alter surgical practice. Loss of patient follow-up is another limitation that may underestimate the true incidence of mesh/suture exposure. In addition, it is difficult to determine the directionality of the relationship between length of follow-up and mesh/suture exposure status because of the retrospective nature of our case-control study. The possibility exists that both longer follow-up leads to increased mesh/suture exposure detection rates and that mesh/suture exposure detection rates result in longer follow-up of this complication. Strengths of this study include a large sample size.
In conclusion, ultralightweight polypropylene mesh neither increases nor decreases mesh/suture exposure after multivariate regression analysis compared with heavier polypropylene meshes. In addition, polyester suture is not recommended for vaginal mesh attachment, given the growing body of literature supporting monofilament use without the risk of sacrocolpopexy failure.
